Invention Grant
- Patent Title: EP4 antagonists
-
Application No.: US17141557Application Date: 2021-01-05
-
Publication No.: US11434246B2Publication Date: 2022-09-06
- Inventor: Wanjun Zheng , Xiaojie Zhu , Hong Du , Maarten Postema , Yimin Jiang , Jing Li , Robert Yu , Hyeong-Wook Choi , Jaemoon Lee , Francis G. Fang , Daniel Custar
- Applicant: Eisai R&D Management Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: BD252/2016 20161013
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61P35/00
Abstract:
We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
Public/Granted literature
- US20210347779A1 EP4 ANTAGONISTS Public/Granted day:2021-11-11
Information query
